No Data
No Data
No Data
No Data
No Data
Summit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024
Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") will host an earnings call to announce its first quarter 2024 financial results and provide an operational update for the Company on Wednesday, May 1, 2024, before the market opens.
Businesswire04:30
Daily rights tracking | Bitcoin hits 67,000 US dollars, crypto mining companies are in high demand
Tesla surged more than 12% before the market, and overnight options traded 1.75 million, with a bearish ratio of 55.2%. More than 53,000 PUT transactions due on Friday with an exercise price of 140 US dollars topped the list.
Futu NewsApr 24 17:17
Daily rights tracking | Trump's media rose 40% in two days! Earn eight times the option premium with a single call
Tesla's multiple single options due today doubled and surged; TSMC options trading volume surged by nearly 60%, slightly rising to 68% from a bullish ratio.
Futu NewsApr 19 17:03
Summit Therapeutics Appoints Biotech Veteran to Board
TipRanksApr 12 04:52
Summit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned Executive and Genomicist, to Its Board of Directors
Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that Mostafa Ronaghi, PhD, has been appointed to its Board of Directors, effective immediately.
BusinesswireApr 12 04:30
Analysts Offer Insights on Healthcare Companies: Avita Medical (RCEL), Summit Therapeutics (SMMT) and Neurocrine (NBIX)
TipRanksApr 11 19:30
No Data
No Data